Back to top

gene-therapy: Archive

Zacks Equity Research

PGEN Stock Surges 144% in August on FDA Nod for Rare Lung Disease Drug

Precigen stock soars 144% in August after FDA approval of Papzimeos, the first treatment for adults with recurrent respiratory papillomatosis.

INOPositive Net Change CRMDPositive Net Change KNSAPositive Net Change PGENPositive Net Change